|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided (required) by operating activities | |||||
| Depreciation and amortization | |||||
| Impairment of properties | |||||
| Deferred and noncurrent income tax charges (benefits) | |||||
| Restructuring expense, net of cash paid | |||||
| Accretion of asset retirement obligations | |||||
| Amortization of discount on marketable securities | |||||
| (Gains) losses from sale of assets | |||||
| Net (increases) decrease in noncash operating working capital | |||||
| Other operating activities - net | |||||
| Net cash provided (required) by operating activities | |||||
| Investing Activities | |||||
| Property additions | |||||
| Payments for acquisition, net of cash acquired | |||||
| Proceeds from sale of assets | |||||
| Investment in marketable securities | |||||
| Redemptions of marketable securities | |||||
| Other investing activities - net | |||||
| Net cash provided (required) by investing activities | |||||
| Financing Activities | |||||
| Purchase of treasury stock | |||||
| Dividends paid | |||||
| Borrowings of debt | |||||
| Repayments of debt | |||||
| Debt issuance costs | |||||
| Amounts related to share-based compensation | |||||
| Net cash provided (required) by financing activities | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at January 1 | |||||
| Cash, cash equivalents and restricted cash at December 31 | |||||
Loading...
